Op-Ed: Put NJ patients ahead of pharmacy benefit managers

Sherrill's op-ed highlights the critical issue of pharmacy benefit managers' practices that hinder drug access for New Jersey patients. By advocating against these middlemen, Sherrill calls for legislative action to prioritize patient care over corporate interests. This move is significant as it could lead to more affordable and accessible medications for residents, addressing a long-standing problem in healthcare. Lawmakers' response to this call will determine whether patients' needs are finally put first.